Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On January 22, 2020, the Board of Directors (the "Board") of Turning Point Therapeutics, Inc. (the "Company"), upon recommendation of the Nominating and Corporate Governance Committee of the Board, appointed Garry Nicholson as a Class I director of the Company, and as a member of the Nominating and Corporate Governance Committee and the Compensation Committee of the Board, with a term of office expiring at the 2020 annual meeting of stockholders. There are no arrangements or understandings between Mr. Nicholson and any other person pursuant to which he was selected as a director. In addition, there are no transactions in which Mr. Nicholson has an interest that would require disclosure under Item 404(a) of Regulation S-K.

Pursuant to the Company's compensation policy for non-employee directors (the "Compensation Policy"), Mr. Nicholson (i) will receive an annual cash retainer of (a) $40,000 for service on the Board, (b) $5,000 for service as a member of the Compensation Committee of the Board and (c) $4,000 for service as a member of the Nominating and Corporate Governance Committee of the Board, and (ii) was granted on the date of his appointment an option to purchase 25,000 shares of the Company's common stock, which vests monthly over a three-year period. The Compensation Policy also provides for further automatic annual option grants to purchase 12,500 shares of the Company's common stock on the date of each annual meeting of stockholders, which vest in full on the one-year anniversary of the date of grant. Each of the option grants described above will vest in full in the event of a change in control (as defined in the Company's 2019 equity incentive plan) provided Mr. Nicholson remains in continuous service with the Company as of immediately prior to such change in control. Mr. Nicholson has also entered into the Company's standard form of Indemnity Agreement for directors of the Company.

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses